Stay updated on CARDINAL Trial: Bardoxolone Methyl in Alport Syndrome
Sign up to get notified when there's something new on the CARDINAL Trial: Bardoxolone Methyl in Alport Syndrome page.

Latest updates to the CARDINAL Trial: Bardoxolone Methyl in Alport Syndrome page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe study record history now shows a new Revision: v3.6.5 tag, replacing the previous Revision: v3.6.4, reflecting a small page update.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedA new revision entry 'Revision: v3.6.4' is added to the study record versions, while the previous 'Revision: v3.6.3' is removed, indicating an update to the record's history.SummaryDifference0.1%

- Check44 days agoChange DetectedA new revision entry 'Revision: v3.6.3' was added to the history, and the previous 'Revision: v3.6.2' entry was removed from the list.SummaryDifference0.1%

- Check51 days agoChange DetectedA new revision tag v3.6.2 was added to the study record history and the previous tag v3.6.0 was removed, updating the page's version history to reflect the latest revision.SummaryDifference0.1%

- Check65 days agoChange DetectedThe study's recruitment status was updated to No longer looking for participants, reflecting the end of enrollment; a new page revision v3.6.0 was added and the previous revision v3.5.5 was removed.SummaryDifference0.3%

- Check72 days agoChange DetectedThe study history now shows Revision: v3.5.5, replacing the previous v3.5.4. This indicates a new revision entry was recorded in the history.SummaryDifference0.1%

Stay in the know with updates to CARDINAL Trial: Bardoxolone Methyl in Alport Syndrome
Enter your email address, and we'll notify you when there's something new on the CARDINAL Trial: Bardoxolone Methyl in Alport Syndrome page.